Simultaneous Estimation of Aliskiren and Valsartan by Using Hplc - L. Kalyani - Libros - LAP LAMBERT Academic Publishing - 9783659157332 - 14 de marzo de 2014
En caso de que portada y título no coincidan, el título será el correcto

L. Kalyani
Simultaneous Estimation of Aliskiren and Valsartan by Using Hplc

Precio
$ 39,49
sin IVA

Pedido desde almacén remoto

Entrega prevista 23 de jun. - 6 de jul.

Nuestros clientes opinan:

Política de devolución de 14 días conforme a la legislación europea de protección de los consumidores
Mejor valorado en Trustpilot
Añadir a tu lista de deseos de iMusic

This work is aimed to develop a simple, precise and accurate HPLC method for the assay of Aliskiren and Valsartan. Aliskiren hemifumarate is a direct renin inhibitor and is indicated for essential hypertension. Valsartan is a nonpeptide specific angiotensin II receptor blocker and is indicated for the treatment of hypertension. The combination of Aliskiren and Valsartan is indicated for the treatment of hypertension. Hence the objective of this research work is to develop and validate a HPLC method for the simultaneous estimation of Aliskiren and Valsartan in bulk drug and pharmaceutical dosage forms as per ICH guidelines. Various trials were carried out for the optimization of the HPLC method for simultaneous estimation of Aliskiren and Valsartan.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 14 de marzo de 2014
ISBN13 9783659157332
Editores LAP LAMBERT Academic Publishing
Páginas 56
Dimensiones 150 × 3 × 226 mm   ·   102 g
Lengua Alemán  

Ver todo de L. Kalyani ( Ej. Paperback Book )